Cellectis S.A.
CLLSNASDAQHealthcareBiotechnology
As of Oct 15, 2026 close
- Market cap
- $111.22M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $1.09$5.48
- Volume (live)
- -
- Avg. volume (3M)
- 164.78K
Cellectis (CLLS) Stock Price & Financial Analysis
Cellectis Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $1.09 - $1.14 |
|---|---|
| 52-Week High | $5.48 |
| 52-Week Low | $1.09 |
| Open | $1.14 |
| Volume (last close) | 101.43K |
| Average Volume (3M) | 164.78K |
| Revenue (TTM) | 56.59M |
|---|---|
| Net Income (TTM) | -65.38M |
| Free Cash Flow (TTM) | -43.92M |
| EPS (TTM) | −$0.65 |
| Profit Margin | -115.52% |
| Operating Margin | -105.89% |
| Return on Equity (ROE) | -159.20% |
| Debt to Equity | 1.31 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 111.22M |
|---|---|
| Shares Outstanding | 100.65M |
| Price to Sales (P/S) | 1.97 |
| Price to Book (P/B) | 2.71 |
| EV/EBITDA | -2.60 |
| 50-Day MA | $2.36 |
|---|---|
| 200-Day MA | $3.28 |
| 1-Year Change | −75.55% |
Source: Market prices and company fundamentals. Data as of Oct 15, 2026. Data sources and methodology
Cellectis at a Glance
As of the Oct 15, 2026 close, Cellectis (CLLS) has a market capitalization of $111.22M. The stock trades at 2.0× sales. Over the trailing twelve months it lost $65.38M on revenue of $56.59M and burned $43.92M of free cash flow. Revenue grew 3.2% year over year.
As of its latest reported balance sheet, it holds $35.59M in cash and securities against $53.98M of debt, a net debt position of $18.39M.
Cellectis does not currently pay a dividend.
The share price is down 75.6% over the past year. At $1.10 (the Oct 15, 2026 close) it sits near the bottom of its 52-week range of $1.09 to $5.48, below its 200-day moving average of $3.28.
Based on 4 professional analyst ratings from the past 90 days, the consensus is Hold with an average price target of $4.10, 271.0% above the Oct 15, 2026 close.
Frequently Asked Questions About Cellectis
What is the current stock price for CLLS?
As of the Oct 15, 2026 close, CLLS stock trades at $1.10. The 52-week range is $1.09–$5.48, with a day range of $1.09–$1.14.
What is the P/E ratio for CLLS?
The P/E ratio (Price-to-Earnings) for CLLS is shown in the Key Statistics section. This valuation metric helps compare Cellectis S.A. to industry peers.
Does CLLS pay dividends?
Cellectis does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for CLLS?
Based on ratings from 4 professional analysts over the last 90 days, the consensus for CLLS is Hold. The average 12-month price target is $4.10, a 271.0% upside from the Oct 15, 2026 close of $1.10.
What is the market cap of CLLS?
As of the Oct 15, 2026 close, Cellectis's market capitalization is $111.2M, classifying it as a micro-cap company. Cellectis operates in the Healthcare sector within the Biotechnology industry.